Details for Patent: 9,180,125
Which drugs does patent 9,180,125 protect, and when does it expire?
Patent 9,180,125 protects RELISTOR and is included in two NDAs.
This patent has thirty-eight patent family members in eighteen countries.
Summary for Patent: 9,180,125
| Title: | Peripheral opioid receptor antagonists and uses thereof |
| Abstract: | The present invention provides a compound of formula I: wherein X−, R1, and R2 are as defined herein, and compositions thereof. |
| Inventor(s): | Nataliya BAZHINA, George Joseph Donato, III, Steven R. Fabian, John Lokhnauth, Sreenivasulu Megati, Charles Melucci, Christian Ofslager, Niketa Patel, Galen Radebaugh, Syed M. Shah, Jan Szeliga, Huyi Zhang, Tianmin Zhu |
| Assignee: | Wyeth LLC |
| Application Number: | US14/322,382 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,180,125 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,180,125
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salix Pharms | RELISTOR | methylnaltrexone bromide | SOLUTION;SUBCUTANEOUS | 021964-002 | Sep 27, 2010 | RX | Yes | Yes | 9,180,125 | ⤷ Start Trial | Y | TREATMENT OF OPIOID-INDUCED CONSTIPATION | ⤷ Start Trial | |||
| Salix Pharms | RELISTOR | methylnaltrexone bromide | SOLUTION;SUBCUTANEOUS | 021964-001 | Apr 24, 2008 | RX | Yes | Yes | 9,180,125 | ⤷ Start Trial | Y | TREATMENT OF OPIOID-INDUCED CONSTIPATION | ⤷ Start Trial | |||
| Salix Pharms | RELISTOR | methylnaltrexone bromide | SOLUTION;SUBCUTANEOUS | 021964-003 | Sep 27, 2010 | RX | Yes | Yes | 9,180,125 | ⤷ Start Trial | Y | TREATMENT OF OPIOID-INDUCED CONSTIPATION | ⤷ Start Trial | |||
| Salix | RELISTOR | methylnaltrexone bromide | TABLET;ORAL | 208271-001 | Jul 19, 2016 | RX | Yes | Yes | 9,180,125 | ⤷ Start Trial | Y | TREATMENT OF OPIOID-INDUCED CONSTIPATION | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,180,125
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 073520 | ⤷ Start Trial | |||
| Australia | 2009298500 | ⤷ Start Trial | |||
| Brazil | 122020013665 | ⤷ Start Trial | |||
| Brazil | PI0919539 | ⤷ Start Trial | |||
| Canada | 2676881 | ⤷ Start Trial | |||
| China | 102307874 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
